Picture of Shield Therapeutics logo

STX Shield Therapeutics News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

REG - Shield Therapeutics - RetailBook Offer

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241206:nRSF1732Pa&default-theme=true

RNS Number : 1732P  Shield Therapeutics PLC  06 December 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE
OR IN PART, OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, NEW ZEALAND,
CANADA, SOUTH AFRICA OR JAPAN, OR ANY MEMBER STATE OF THE EEA, OR ANY OTHER
JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO MIGHT CONSTITUTE
A VIOLATION OR BREACH OF ANY APPLICABLE LAW OR REGULATION. PLEASE SEE THE
IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS
RELATING TO THE RETAILBOOK OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE
TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING
WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL
PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF SHIELD
THERAPEUTICS PLC).  ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS
ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN
ONLY WITH SUCH PERSONS. THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY,
AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR
ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY
SECURITIES OF SHIELD THERAPEUTICS PLC.

 

 

6 December 2024

 

Shield Therapeutics plc

 

("Shield" or the "Company")

 

RetailBook Offer

 

·    Shield is pleased to announce a conditional RetailBook Offer of new
ordinary shares of 1.5p each in the capital of the Company ("Ordinary Shares")
via RetailBook (https://www.retailbook.com/) (the "RetailBook Offer Shares");

·    The offer price for each new RetailBook Offer Share is 3.0p per share
(the "Offer Price"), representing a premium of 5.3 per cent to the closing
mid-price of the Company's existing Ordinary Shares on 5 December 2024;

·    Investors can take part through RetailBook's partner network of
participating retail brokers, wealth managers and investment platforms, which
includes AJ Bell, Hargreaves Lansdown and interactive investor;

·    Applications for RetailBook Offer Shares through these partners can
be made from tax efficient savings vehicles such as ISAs or SIPPs, as well as
General Investment Accounts ("GIAs");

·    The RetailBook Offer is available to existing shareholders only;

·    There is a minimum subscription of £50 per investor in the
RetailBook Offer;

·    A maximum of 33,333,333 RetailBook Offer Shares will be issued and
accordingly, the maximum gross proceeds of the RetailBook Offer are
£1,000,000

·    The RetailBook Offer is expected to close at 4.30 p.m. on 20 December
2024;

·    Completion of the RetailBook Offer is conditional on the completion
of the Subscription and admission of the RetailBook Offer Shares to trading on
AIM;

·    No commission will be charged by RetailBook on applications to the
RetailBook Offer.

 

 

The RetailBook Offer

 

Shield is pleased to announce a conditional RetailBook Offer for of new
RetailBook Offer Shares via RetailBook (the "RetailBook Offer") at an Offer
Price of 3.0p per RetailBook Share, being a premium of 5.3 per cent to the
closing mid-price of the Company's existing Ordinary Shares on 5 December
2024.

 

Earlier today the Company also announced a conditional subscription for new
Ordinary Shares (the "Subscription Shares") by its existing shareholder, AOP
Health International Management AG ("AOP") (the "Subscription"). For the
avoidance of doubt, the RetailBook Offer is not part of the Subscription.

 

The issue of the RetailBook Offer Shares will be conditional upon completion
of the Subscription and will be undertaken pursuant to the authorities granted
to the Directors at the Company's Annual General Meeting held on 20 June 2024.
The issue of the Subscription Shares is conditional on the passing of all
resolutions relating to the Subscription (the "Resolutions") at a general
meeting of the Company to be held at Northern Design Centre, Baltic Business
Quarter, Gateshead Quays, Newcastle NE8 3DF at 09:30 a.m.  on 24 December
2024 (the "General Meeting") and the admission of the Subscription Shares to
trading on AIM.

 

Subject to the Resolutions being passed at the General Meeting, it is expected
that the Subscription Shares and such number of RetailBook Offer Shares as are
subscribed for will be admitted to trading on AIM at 8.00 a.m. on 30 December
2024.

 

 

Reason for the RetailBook Offer

 

The Company values its retail shareholder base and believes that it is in the
best interests of shareholders as well as wider stakeholders, to provide its
existing retail shareholders in the United Kingdom, the opportunity to
participate in the RetailBook Offer.

 

The RetailBook Offer is open to existing shareholders of the Company who are
eligible investors in the United Kingdom following release of this
announcement. The RetailBook Offer is expected to close at 4.30 p.m. on 20
December 2024 and may close earlier at the discretion of the Company or if it
is oversubscribed.

 

Investors can participate through RetailBook's partner network of investment
platforms, retail brokers and wealth managers, subject to such partners'
participation. Participating partners include:

 

·    AJ Bell;

·    Hargreaves Lansdown; and

·    interactive investor

 

Applications for RetailBook Offer Shares through participating partners can be
made from tax efficient savings vehicles such as ISAs or SIPPs, as well as
GIAs. Investors wishing to apply using their ISA, SIPP or GIA should contact
their investment platform, retail broker or wealth manager for details of
their terms and conditions, process and any relevant fees or charges.

 

The RetailBook Offer Shares will, when issued, be credited as fully paid and
will rank pari passu in all respects with existing Ordinary Shares including
the right to receive all dividends and other distributions declared, made or
paid after their date of issue.

 

 

Eligibility for the RetailBook Offer

 

The RetailBook Offer is available to existing shareholders of Shield only. To
be eligible to participate in the RetailBook Offer, applicants must be a
customer of a participating intermediary and, as at the date hereof, must be a
shareholder in the Company.

 

Eligible investors wishing to subscribe for RetailBook Offer Shares should
contact their investment platform, retail broker or wealth manager to confirm
if they are participating in the RetailBook Offer.

 

There is a minimum subscription of £50 per investor. The terms and conditions
on which investors subscribe will be provided by the relevant financial
intermediaries including relevant commission or fee charges. Note, no
commission will be charged to investors by RetailBook in connection with the
RetailBook Offer.

 

The Company reserves the right to scale back any order under the RetailBook
Offer at its discretion. The Company reserves the right to reject any
application for subscription under the RetailBook Offer without giving any
reason for such rejection.

 

It is important to note that once an application for RetailBook Offer Shares
has been made and accepted via an intermediary, it cannot be withdrawn.
Investors should also note that the RetailBook Offer will remain open
alongside a live share price and the market price of the shares may be less
than the Offer Price.

 

It is a term of the RetailBook Offer that the aggregate value of the shares
available for subscription at the Offer Price does not exceed £1,000,000.

 

Investors should make their own investigations into the merits of an
investment in the Company. Nothing in this announcement amounts to a
recommendation to invest in the Company or amounts to investment, taxation or
legal advice.

 

It should be noted that a subscription for RetailBook Offer Shares and
investment in the Company carries a number of risks. Investors should take
independent advice from a person experienced in advising on investment in
securities such as the RetailBook Offer Shares if they are in any doubt.

 

An investment in the Company will place capital at risk. The value of your
investment in the Company and any income from it is not guaranteed and can go
down as well as rise due to stock market and currency movements. When you sell
your investment, you may get back less than the amount originally invested.

 

Neither past performance nor any forecasts should be considered a reliable
indicator of future results.

 

This announcement should be read in its entirety. In particular, the
information in the "Important Notices" section of the announcement should be
read and understood.

 

 

Enquiries

 

 Shield Therapeutics plc              T: +44 (0) 191 511 8500

 Anders Lundstrom, CEO

 Santosh Shanbhag, CFO

 RetailBook

 Kit Atkinson / Michael Ward          Info@retailbook.com (mailto:Info@retailbook.com)

 Nominated Adviser and Joint Broker

 Peel Hunt LLP                        T: +44 (0)20 7418 8900

 James Steel/Patrick Birkholm

 

Further information on the Company can be found on its website at
www.shieldtherapeutics.com

 

 

 

Important Notices

 

This announcement has been prepared by, and is the sole responsibility of, the
Company.

 

The RetailBook Offer is offered in the United Kingdom under the exemption from
the requirement to publish a prospectus in section 86(1)(e) of FSMA. As such,
there is no need for publication of a prospectus pursuant to the Prospectus
Regulation Rules of the Financial Conduct Authority, or for approval of the
same by the Financial Conduct Authority. The RetailBook Offer is not being
made into any jurisdiction other than the United Kingdom.

 

No offering document, prospectus or admission document has been or will be
prepared or submitted to be approved by the Financial Conduct Authority (or
any other authority) in relation to the RetailBook Offer, and investors'
commitments will be made solely on the basis of the information contained in
this announcement and information that has been published by or on behalf of
the Company prior to the date of this announcement by notification to a
Regulatory Information Service in accordance with the Financial Conduct
Authority's Disclosure Guidance and Transparency Rules, the Market Abuse
Regulation (EU Regulation No. 596/2014) ("MAR") and MAR as it forms part of
United Kingdom law by virtue of the European Union (Withdrawal) Act 2018 (as
amended).

 

This announcement and the information contained herein is not for release,
publication or distribution, directly or indirectly, in whole or in part, in
or into or from the United States (including its territories and possessions,
any state of the United States and the District of Columbia (the "United
States" or "US")), Australia, Canada, New Zealand, Japan, the Republic of
South Africa, any member state of the EEA or any other jurisdiction where to
do so might constitute a violation of the relevant laws or regulations of such
jurisdiction.

 

The RetailBook Offer Shares have not been and will not be registered under the
US Securities Act of 1933, as amended (the "US Securities Act") or under the
applicable state securities laws of the United States and may not be offered
or sold directly or indirectly in or into the United States. No public
offering of the RetailBook Offer Shares is being made in the United States.
The RetailBook Offer Shares are being offered and sold outside the United
States in "offshore transactions", as defined in, and in compliance with,
Regulation S under the US Securities Act. In addition, the Company has not
been, and will not be, registered under the US Investment Company Act of 1940,
as amended.

 

This announcement does not constitute an offer to sell or issue or a
solicitation of an offer to buy or subscribe for RetailBook Offer Shares in
the United States, Australia, Canada, New Zealand, Japan, the Republic of
South Africa, any member state of the EEA or any other jurisdiction in which
such offer or solicitation is or may be unlawful. No public offer of the
securities referred to herein is being made in any such jurisdiction.

The distribution of this announcement may be restricted by law in certain
jurisdictions and persons into whose possession any document or other
information referred to herein comes should inform themselves about and
observe any such restriction. Any failure to comply with these restrictions
may constitute a violation of the securities laws of any such jurisdiction.

 

RetailBook is a proprietary technology platform owned and operated by Retail
Book Limited (registered address at 10 Queen Street Place, London EC4R 1AG;
FRN 994238). Retail Book Limited ("RetailBook") is authorised and regulated in
the United Kingdom by the Financial Conduct Authority, is acting exclusively
for the Company and for no-one else and will not regard any other person
(whether or not a recipient of this announcement) as its client in relation to
the RetailBook Offer and will not be responsible to anyone other than the
Company for providing the protections afforded to its clients, nor for
providing advice in connection with the RetailBook Offer, admission of the
RetailBook Offer Shares to trading on AIM and the other arrangements referred
to in this announcement.

 

The value of Ordinary Shares and the income from them is not guaranteed and
can fall as well as rise due to stock market movements. When you sell your
investment, you may get back less than you originally invested. Figures refer
to past performance and past performance is not a reliable indicator of future
results. Returns may increase or decrease as a result of currency
fluctuations.

 

The information in this announcement is for background purposes only and does
not purport to be full or complete. None of RetailBook or any of its
affiliates, accepts any responsibility or liability whatsoever for, or makes
any representation or warranty, express or implied, as to this announcement,
including the truth, accuracy or completeness of the information in this
announcement (or whether any information has been omitted from the
announcement) or any other information relating to the Company or associated
companies, whether written, oral or in a visual or electronic form, and
howsoever transmitted or made available or for any loss howsoever arising from
any use of the announcement or its contents or otherwise arising in connection
therewith. RetailBook and its affiliates, accordingly disclaim all and any
liability whether arising in tort, contract or otherwise which they might
otherwise be found to have in respect of this announcement or its contents or
otherwise arising in connection therewith.

 

Neither the content of the Company's website (or any other website) nor the
content of any website accessible from hyperlinks on the Company's website (or
any other website) is incorporated into or forms part of this announcement.
The RetailBook Offer Shares to be issued or sold pursuant to the RetailBook
Offer will not be admitted to trading on any stock exchange other than the
London Stock Exchange.

 

It is further noted that the RetailBook Offer is only open to investors in the
United Kingdom who fall within Article 43 of the Financial Services and
Markets Act 2000 (Financial Promotion) Order 2005, as amended (which includes
an existing member of the Company).

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEBGBDDLUGDGSL

Recent news on Shield Therapeutics

See all news